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Abstract
Background: Radiation-induced parotid damage is one of the most common complications in patients with
nasopharyngeal carcinoma (NPC) undergoing radiotherapy (RT). Intravoxel incoherent motion (IVIM) magnetic
resonance (MR) imaging has been reported for evaluating irradiated parotid damage. However, the changes of IVIM
perfusion-related parameters in irradiated parotid glands have not been confirmed by conventional perfusion
measurements obtained from dynamic contrast-enhanced (DCE) MR imaging. The purposes of this study were to
monitor radiation-induced parotid damage using IVIM and DCE MR imaging and to investigate the correlations
between changes of these MR parameters.
Methods: Eighteen NPC patients underwent bilateral parotid T1-weighted, IVIM and DCE MR imaging pre-RT
(2 weeks before RT) and post-RT (4 weeks after RT). Parotid volume; IVIM MR parameters, including apparent
diffusion coefficient (ADC), pure diffusion coefficient (D), pseudo-diffusion coefficient (D*), and perfusion fraction (f);
and DCE MR parameters, including maximum relative enhancement (MRE), time to peak (TTP), Wash in Rate, and
the degree of xerostomia were recorded. Correlations of parotid MR parameters with mean radiation dose, atrophy
rate and xerostomia degree, as well as the relationships between IVIM and DCE MR parameters, were investigated.
Results: From pre-RT to post-RT, all of the IVIM and DCE MR parameters increased significantly (p < 0.001 for ADC,
D, f, MRE, Wash in Rate; p = 0.024 for D*; p = 0.037 for TTP). Change rates of ADC, f and MRE were negatively
correlated with atrophy rate significantly (all p < 0.05). Significant correlations were observed between the change
rates of D* and MRE (r = 0.371, p = 0.026) and between the change rates of D* and TTP (r = 0.396, p = 0.017). The
intra- and interobserver reproducibility of IVIM and DCE MR parameters was good to excellent (intraclass correlation
coefficient, 0.633–0.983).
Conclusions: Early radiation-induced changes of parotid glands could be evaluated by IVIM and DCE MR imaging.
Certain IVIM and DCE MR parameters were correlated significantly.
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Background
Radiotherapy (RT) is the main treatment modality for
patients with nasopharyngeal carcinoma (NPC).
Radiation-induced parotid damage is one of the most
common complications, causing xerostomia, dysphagia
and increased risk of dental caries [1] and severely
reduces the life quality of these patients. Over the past
few years, intensity-modulated radiation therapy (IMRT)
has been introduced for the treatment of NPC to pre-
serve parotid function [2]. However, the parotid glands
are sensitive to radiation [3], and the radiation-induced
parotid damage cannot be completely avoided even with
IMRT [2]. Therefore, it is important to evaluate
radiation-induced parotid damage in a timely manner
preferably to preserve the function of parotid glands.
The severity of xerostomia can be evaluated based on
the radiation morbidity scoring criteria proposed by the
Radiation Therapy Oncology Group (RTOG) [4]. How-
ever, this evaluation is subjective and cannot depict the
morphological and pathophysiological changes in the irra-
diated parotid glands. Histological examination, which is
the gold standard for the evaluation of radiation-induced
parotid damage, is not suitable for routine clinical use due
to its invasiveness. Scintigraphy, which reveals functional
changes in irradiated parotid glands [5], involves add-
itional radiation exposure. Magnetic resonance (MR)
sialography can noninvasively depict irradiated parotid
ductal damage [6], however without any parenchymal in-
formation about the irradiated parotid glands.
To investigate the structural and pathophysiological
changes, dynamic contrast-enhanced (DCE) and diffusion-
weighted (DW) MR imaging have been used for the evalu-
ation of irradiated parotid glands [7–10]. Changes of the
vascular permeability and extra-vascular extra-cellular
space (EES) in the irradiated parotid glands can be success-
fully evaluated using DCE MR parameters (such as the
transfer coefficient Ktrans and extra-vascular extra-cellular
space ve). However, DCE MR imaging involves intra-
venous injection of gadolinium-based contrast agents,
which cause additional expenditure and incur risks of
nephrogenic systematic fibrosis or gadolinium depos-
ition in the brain. DW MR imaging generates an ap-
parent diffusion coefficient (ADC), which is affected
by both water molecular diffusion and microvascular
perfusion simultaneously.
Intravoxel incoherent motion (IVIM) MR imaging was
initially proposed by Le Bihan et al. [11]. The perfusion
and diffusion information can be separately extracted
using IVIM MR imaging with a number of b values. The
signal decay at low b values is primarily attributed to per-
fusion, while data obtained at high b values are mainly
dominated by diffusion [12]. Microcirculation changes can
be evaluated by IVIM perfusion-related parameters (perfu-
sion fraction f and pseudo-diffusion coefficient D*), and
the pure molecular diffusion (D) can reflect the Brownian
movement of water molecules. In recent years, IVIM MR
imaging has been widely used for the assessment of
organic damage, differential diagnosis of tumours and
monitoring of cancer therapy [13–16]. Marzi et al. found
that IVIM MR parameters (ADC, ADClow, D and f) of
parotid glands significantly changed during RT, and the
changes in D values were significantly correlated with
mean radiation dose [9]. This pilot study indicated the
potential of IVIM MR imaging for the evaluation of
radiation-induced damage to the parotid glands. However,
the changes of IVIM perfusion-related parameters in this
pilot study have not been confirmed by conventional per-
fusion measurements obtained from DCE MR imaging.
Additionally, the precise correlation between IVIM
perfusion-related and DCE MR parameters has not been
confirmed. Jia et al. reported a significant correlation
between f and DCE MR parameters (including Enhance-
ment Amplitude and Maximum Slope of Increase) in
NPC [17]. However, Yuan et al. found no correlations
between IVIM and DCE MR parameters in lung neo-
plasms [18]. To our knowledge, the correlations between
parameters derived from IVIM and DCE MR imaging in
irradiated parotid glands have never been reported.
Therefore, the purposes of this study were to observe
the changes in and the relationships between IVIM and
DCE MR parameters of irradiated parotid glands after
RT and then to correlate the change rates in parotid
IVIM and DCE MR parameters with mean radiation
dose, atrophy rate and xerostomia degree.
Methods
Patients
This study was approved by the institutional review
board of our hospital, and all of the patients provided
written informed consent. From August 2015 to April
2016, 18 patients (male, 14; female, 4; age, 24–70 years
old; mean age, 50.1 ± 10.3 years) with an initial diagnosis
of poorly differentiated NPC were prospectively enrolled.
The inclusion criteria were: (1) a pathological diagnosis
of poorly differentiated NPC through biopsy and readi-
ness to receive IMRT with concurrent chemotherapy in
our hospital; (2) scheduled to undergo MR evaluation
and follow-up in our hospital; and (3) no any history of
allergy to gadolinium contrast agents, with a glomerular
filtration rate greater than 30 mL/min to accommodate
the injection of contrast agents. The exclusion criteria
included: (1) absolute MR examination contraindica-
tions, such as cardiac pacemakers, aneurysm clips, artifi-
cial cochlea implantation, etc.; (2) a history of parotid
disorders, such as parotitis, parotid tumours, etc.; and
(3) having received RT to the head and neck region in
the past. The patients’ characteristics and the flowchart
of this study are shown in Table 1 and Fig. 1, respectively.
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All of the patients were treated with IMRT to the
nasopharyngeal lesions and the neck lymphatic drainage
areas, combined with concurrent chemotherapy (three
cycles; nedaplatin 60 mg for each cycle). The total accu-
mulated radiation dose within the tumour region was
70Gy, which was divided into two courses. In the first
course, the RT field covered the nasopharyngeal lesions
and neck lymphatic drainage areas (25 fractions; 2 Gy
for each fraction). In the second course, the RT field was
reduced to the tumour area according to the CT reset
condition (10 fractions; 2 Gy for each fraction). The RT
was administered as one fraction for 1 day, five fractions
for 1 week and a total of 35 fractions for 7 weeks. Be-
cause the bilateral parotid and submandibular glands
were quite close to the planning target volume (PTV),
some attempt was undertaken to reduce their radiation
doses on the premise of meeting the tumour exposure
dose. The mean accumulated radiation dose to the par-
otid glands was calculated from the treatment planning
system of Pinnacle3 (Philips Medical Systems, Fitchburg,
WI, USA) and TomoTherapy HiArt (TomoTherapy,
Madison, WI, USA). Because the bilateral parotid glands
received different radiation doses during the course of
RT, the bilateral parotid glands of each patient were ana-
lysed separately. The mean total accumulated radiation
dose to the parotid glands was 28.4 ± 2.4 Gy after RT,
which was less than our hospital limit for parotid
radiation dose of 30–35 Gy for 50 % volume. All of the
patients underwent two MR examinations within 2 weeks
before RT (pre-RT) and 4 weeks after RT (post-RT), and
the MR scan protocol remained identical during the
course. All of the patients successfully underwent the
whole therapy and follow-up MR examinations.
Clinical assessment of xerostomia
The degree of xerostomia in NPC patients was assessed
1 hour prior to each MR examination by a radiation on-
cologist (X.X., with 10 years of clinical experience in
head and neck RT), according to the acute radiation
morbidity scoring criteria proposed by the Radiation
Therapy Oncology Group (RTOG) [4]: grade 0 is no
change over baseline; grade 1 indicates mild mouth dry-
ness or slightly thickened saliva but without alterations
in the baseline feeding behaviour, such as the increased
use of liquids with meals; grade 2 represents moderate
dryness or sticky saliva; grade 3 indicates complete
dryness; and grade 4 characterizes acute salivary gland
necrosis. The grade of xerostomia in each patient at each
time was recorded.
MR imaging
All of the patients were asked to fast for 2 h before each
MR examination. A full digital 3.0 T MR scanner (Ingenia,
Table 1 Clinical data of NPC patients undergoing radiotherapy
NO. Age ranges
(years)
Radiation dose (Gy) Xerostomia degree
R L Pre-RT Post-RT
1 51–60 28.5 27.5 0 1
2 61–70 25.6 26.9 0 2
3 41–50 26.0 25.9 0 1
4 41–50 25.8 25.0 0 2
5 51–60 25.5 25.9 0 1
6 21–30 32.6 34.3 0 1
7 51–60 30.4 33.2 0 2
8 61–70 30.3 29.9 0 1
9 61–70 27.7 28.8 0 1
10 41–50 28.1 28.1 0 1
11 51–60 31.0 29.7 0 2
12 51–60 30.8 31.5 0 2
13 41–50 29.0 28.8 0 2
14 41–50 27.6 27.0 0 1
15 51–60 29.9 30.9 0 2
16 41–50 25.3 24.8 0 2
17 41–50 25.8 26.7 0 2
18 41–50 28.9 27.9 0 1
NPC nasopharyngeal carcinoma, pre-RT approximately 2 weeks before
radiotherapy (RT), post-RT approximately 4 weeks after RT, R right parotid
gland, L left parotid gland. Xerostomia degree was evaluated by the acute
radiation morbidity scoring criteria proposed by the Radiation Therapy
Oncology Group (RTOG)
Fig. 1 Flowchart describes the procedures of MR examinations and radiotherapy (RT) for patients with nasopharyngeal carcinoma. Pre-MR and
post-MR are the MR examinations within 2 weeks before RT (pre-RT) and 4 weeks after RT (post-RT), respectively. CT reset scanning proceeded
approximately 5 weeks after the beginning of RT for the formulation of the second course RT scheme
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Philips Medical Systems, Best, the Netherlands) was used
for the MR examinations, with a 16-channel head/neck
phased array coil. Patients were placed in the supine
position with the head first. The scanning sequences in-
cluded: transverse T1-weighted (T1W) imaging, intravoxel
incoherent motion (IVIM) MR imaging and dynamic
contrast-enhanced (DCE) MR imaging. The total duration
of the MR examination was approximately 10 min, 9 s.
T1W imaging was obtained with a turbo spin-echo (TSE)
sequence. The other parameters were as follows: repetition
time/echo time: 400–675 msec/18 msec; TSE factor: 8;
matrix: 276 × 215; slice thickness: 5 mm; slice gap: default;
slices: 38; field of view: 22 cm; voxel size: 0.8 mm×
0.92 mm; and number of signals averaged: 2. The duration
of T1W imaging was approximately 2 min, 27 s.
IVIM MR imaging was obtained with a single-shot
echo-planar imaging (SS-EPI) sequence with spectral
presaturation attenuated inversion recovery (SPAIR) fat
suppression before the injection of the gadolinium con-
trast agent. A volume shim covering the region of bilat-
eral parotid glands was used to minimize susceptibility
artefacts. The other parameters were as follows: repeti-
tion time/echo time: 6000 msec/shortest; matrix: 84 ×
104; slice thickness: 4 mm; slice gap: 0.4 mm; slices: 22;
field of view:22 cm; voxel size: 2.5 mm × 2.08 mm; and
number of signals averaged: 2. A total of 9 b values (0, 25,
50, 75, 100, 150, 200, 500, and 800 s/mm2) were applied in
the IVIM MR imaging. The duration of the IVIM MR
imaging sequence was approximately 5 min, 6 s.
DCE MR imaging was obtained with a three-
dimensional (3D) T1-fast field echo (FFE) sequence. Intra-
venous bolus injection of gadodiamide (0.2 mL/kg
bodyweight, GE Healthcare Ireland, Shanghai, China) was
administered at a rate of 3.0 mL/s followed by a 15 mL
saline flush using an automatic power injection (Medrad
Spectris Solaris EP MR Injector System; One Medrad
Drive Indianola, PA, USA). The other parameters were as
follows: repetition time/echo time: shortest/shortest; flip
angle: 10°; matrix: 232 × 232; slice thickness: 2 mm; slice
gap: default; slices: 68; field of view:30 cm; voxel size:
1.3 mm× 1.29 mm; and number of signals averaged: 1. A
total of 15 dynamics at an interval of 10.4 s were obtained
for each patient. The duration of the DCE MR sequence
was approximately 2 min, 36 s.
All of the patients completed all of the MR examina-
tions successfully without any discomfort or side effects.
Image analysis
All the MR images were analysed and measured inde-
pendently by 2 radiologists (X.X., X.X.X.) with 3 and
11 years of experience, respectively, in head and neck
radiology, who were blinded to the clinical information
of all of the patients. Averaged values of the two
radiologists’ measurements were treated as the final
results for the parotid glands.
T1W images were transferred into a workstation (Ex-
tended MR WorkSpace 2.6.3.5, Philips Medical Systems,
Best, the Netherlands), which was used to calculate the par-
otid volume owing to its perfect soft tissue contrast. The
outline of each parotid gland was drawn slice by slice on
T1W images to obtain the area of each slice. The volume
of each parotid gland was calculated by the following equa-
tion: V =∑Si × (ST + SG), where V represents the volume of
the parotid gland, Si represents the area of the ith slice in
the parotid gland, ST represents the slice thickness, and SG
represents the slice gap. The atrophy rate of each parotid
gland from pre-RT to post-RT was calculated by the follow-
ing equation: RV = (Vpre–Vpost) / Vpre × 100 %, where RV is
the atrophy rate of the parotid gland, and Vpre and Vpost are
the parotid volume pre-RT and post-RT, respectively.
IVIM MR images were post-processed using DWI-
Tool, developed by Philips in IDL 6.3 (ITT Visual Infor-
mation Solutions, Boulder, CO, USA). D, D* and f maps
were generated using the bi-exponential fit equation
[19]: Sb/S0 = (1–f ) ∙ exp (−bD) + f ∙ exp [−b (D + D*)],
where Sb represents the mean signal intensity at differ-
ent b values of 25, 50, 75, 100, 150, 200, 500, and 800 s/
mm2, S0 represents the mean signal intensity at a b value
of 0 s/mm2, f represents the fraction of diffusion linked
to microcirculation, exp is exponential, D represents the
slow component of diffusion, and D* represents the fast
component of diffusion. The ADC map was generated
using the mono-exponential fit equation [19]: ln (Sb) = ln
(S0)−bADC, where ADC represents the microscopic
translational motions, including the pure molecular dif-
fusion and perfusion-related diffusion. A region of inter-
est (ROI) was delineated manually on the largest slice of
the IVIM MR images for each parotid gland to include
as much as parotid parenchyma without obvious vessels.
The ROI was automatically transferred between mono-
exponential and bi-exponential models, and the
corresponding D, D*, f and ADC values of the parotid
glands were obtained. The change rates of D, D*, f and
ADC values were calculated by the following equation:
RIVIM-PARs = (IVIM-PARpost−IVIM-PARpre) / IVIM-
PARpre × 100 %, where RIVIM-PARs is the change rate of
D, D*, f and ADC values from pre-RT to post-RT, and
IVIM-PARpost and IVIM-PARpre are the D, D*, f and
ADC values post-RT and pre-RT, respectively.
DCE MR images were post-processed using the “Basic
T1 Perfusion” function on the aforementioned worksta-
tion. The time-intensity curve was depicted automatic-
ally, and the DCE MR parameters, including the
maximum relative enhancement (MRE), time to peak
(TTP) and Wash in Rate, were calculated. MRE is the
maximal signal enhancement of a pixel of certain
dynamic relative to that same pixel with the pre-contrast
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dynamic. TTP is the time between the time of initial in-
tensity and the time of peak intensity. Wash in Rate is the
maximum slope between the time of initial intensity and
the time of peak intensity. An ROI was drawn manually
on the largest slice of the parotid gland to include as much
as parotid parenchyma with visible vessels excluded, and
the corresponding MRE, TTP and Wash in Rate were
automatically obtained. The change rates of the MRE,
TTP and Wash in Rate were calculated by the following
equation: RDCE-PARs = (DCE-PARpost−DCE-PARpre) /
DCE-PARpre × 100 %, where RDCE-PARs is the change rate
of MRE, TTP and Wash in Rate from pre-RT to post-RT,
and DCE-PARpost and DCE-PARpre are the MRE, TTP
and Wash in Rate post-RT and pre-RT, respectively.
The IVIM and DCE MR parameters were repeatedly
measured by the second observer with an interval of
4 weeks between measurements to evaluate intraobser-
ver reproducibility.
Statistical analysis
Continuous numeric data with normal distribution are re-
ported as the means ± standard deviations (SD). The paired
sample t test was used to identify any significant changes of
IVIM and DCE MR parameters from pre-RT to post-RT.
The differences of averaged bilateral parotid RIVIM-PARs and
RDCE-PARs between grade 1 and grade 2 of the post-RT xer-
ostomia degree were analysed using the independent-
samples t test. Pearson’s correlation test was used to detect
the correlations between the change rates of parotid IVIM
and DCE MR parameters and mean radiation dose or atro-
phy rates, as well as between the change rates of IVIM and
DCE MR parameters. The intra- and interobserver repro-
ducibility of IVIM and DCE MR parameters was evaluated
by calculating intraclass correlation coefficient (ICC) values.
The ICC was between 0 and 1, and the interpretation of
ICC was as follows: < 0.20, poor; 0.21–0.40, fair; 0.41–0.60,
moderate; 0.61–0.80, good; and > 0.80, excellent [20]. Statis-
tical analysis was performed using SPSS software, version
16.0 (SPSS Inc., Chicago, IL, USA). A two-tailed p values <
0.05 was considered statistically significant.
Results
From pre-RT to post-RT, the volume of bilateral parotid
glands significantly decreased from 26.1 ± 5.5 cm3 to
18.9 ± 3.9 cm3, with an atrophy rate of 26.5 ± 10.3 % (p <
0.001). The pre- and post-RT IVIM and DCE MR im-
ages of the bilateral parotid glands in one representative
NPC patient are shown in Fig. 2.
Changes of IVIM and DCE MR parameters from pre-RT to
post-RT
As shown in Table 2, all of the IVIM and DCE MR pa-
rameters increased from pre-RT to post-RT significantly
(all p < 0.05).
Correlations between changes of IVIM or DCE MR
parameters and atrophy rate (and mean radiation dose)
As shown in Table 3 and Fig. 3, the change rates of par-
otid ADC, f and MRE were negatively correlated with
the atrophy rate significantly from pre-RT to post-RT
(all p < 0.05). There was no significant correlation
between mean radiation dose and any change rate of
parotid IVIM or any DCE MR parameter (all p > 0.05).
Relationships between IVIM or DCE MR parameters and
xerostomia degree
The average change rates of bilateral parotid IVIM and
DCE MR parameters in patients with grade 1 xerostomia
degree did not significantly differ from that in patients
with grade 2 (all p > 0.05).
Correlations between IVIM and DCE MR parameters
As shown in Table 4, the change rate of D* was corre-
lated with that of MRE (r = 0.371 and p = 0.026) and
TTP (r = 0.396 and p = 0.017) significantly from pre-RT
to post-RT, and there were no significant correlations
between the change rates of other IVIM and DCE MR
parameters.
Reproducibility of IVIM and DCE MR parameters
As shown in Table 5, the measurements of most parotid
IVIM and DCE MR parameters showed excellent intra-
and interobserver agreement (ICC, 0.911–0.983), except
it was good for f and D* (ICC, 0.633–0.793).
Discussion
Xerostomia, which is caused by irradiated parotid dam-
age, is a common complication in NPC patients receiv-
ing RT. Morphological and microstructural changes in
irradiated parotid glands can be noninvasively evaluated
by MR imaging [6, 7, 10]. Tissue perfusion (D*, f ) and
water molecular diffusion (D) features can be quantita-
tively characterized by IVIM MR imaging with bi-
exponential algorithms [11], and tissue perfusion
information about the microcirculation can be described
with semiquantitative DCE MR imaging [21, 22]. In this
study, the changes in irradiated parotid glands from pre-
RT to post-RT were successfully monitored by IVIM
and DCE MR parameters, and correlations between the
change rates of IVIM and DCE MR parameters were
confirmed.
All of the averaged bilateral parotid IVIM MR parame-
ters (including ADC, D, D* and f) increased significantly
from pre-RT to post-RT in this study. Marzi et al.
reported significant increases of parotid ADC, D,
ADClow, and f values in patients with head and neck
cancer from baseline to the completion of RT [9], con-
sistent with our results. The significant increase of ADC
and D values might result from the widespread necrosis
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of acinar cells induced by RT [23], which caused lower
cell density and an augmentation of water molecular dif-
fusion. Houweling et al. reported a significant increase
in ve due to cell loss at 6 weeks after RT in oropharyn-
geal cancer patients [7], in accordance to our hypothesis.
Marzi et al. attributed the increases in parotid ADClow
and f on the same day of the completion of RT to
radiation-induced vascular oedema, which caused vaso-
dilation and an increase in blood volume [9]. We specu-
lated that the increases of D* and f values in our study
shared the same pathophysiologic mechanism. Although
Xu et al. reported that parotid microvascular density
decreased at 4 h after RT [24], we considered the
increase of blood volume secondary to vascular oedema
to be the main effect of RT in the early phase of
radiation-induced parotid damage. Furthermore, Lee et
al. documented a significant increase in parotid vascular
plasma volume (vp) at 3 months after RT in patients
with head and neck cancer, explained by vasodilatation
and increased blood volume induced by inflammation
[25]; we share the same opinion as them.
All of the averaged bilateral parotid DCE MR parame-
ters (including MRE, TTP and Wash in Rate) increased
significantly from pre-RT to post-RT in this study. The
increase of MRE and Wash in Rate might share the
same mechanism that caused the increase of D* and f
Fig. 2 MR images of bilateral parotid glands (arrows) in one patient with nasopharyngeal carcinoma (NPC). a-h Dynamic contrast-enhanced (DCE,
a-d) and intravoxel incoherent motion (IVIM, e-h) MR images within 2 weeks before radiotherapy (pre-RT). i-p DCE (i-l) and IVIM (m-p) MR images
approximately 4 weeks after radiotherapy (post-RT). At pre-RT, the right and left parotid maximum relative enhancement (MRE, b), time to peak
(TTP, c), Wash in Rate (d), apparent diffusion coefficient (ADC, e), pure diffusion coefficient (D, f), perfusion fraction (f, g), and pseudo-diffusion
coefficient (D*, h) values are 222.8 and 243.7 %, 46.8 s and 52.0 s, 143.9 i/s and 100.7 i/s, 0.76 × 10−3 mm2/s and 0.85 × 10−3 mm2/s, 0.69 × 10−3
mm2/s and 0.73 × 10−3 mm2/s, 0.089 and 0.116, and 50.8 × 10−3 mm2/s and 32.2 × 10−3 mm2/s, respectively. At post-RT, the right and left parotid
MRE (j), TTP (k), Wash in Rate (l), ADC (m), D (n), f (o), and D* (p) values are 335.6 and 357.9 %, 62.6 s and 83.5 s, 237.0 i/s and 146.4 i/s, 1.70 × 10
−3 mm2/s and 1.59 × 10−3 mm2/s, 1.41 × 10−3 mm2/s and 1.31 × 10−3 mm2/s, 0.184 and 0.175, and 54.3 × 10−3 mm2/s and 39.0 × 10−3
mm2/s, respectively
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values, that is, vascular oedema and increased blood
volume secondary to inflammation after RT. In addition,
the augmentation of EES due to cell loss also promoted
the accumulation of contrast agent in parotid tissue.
Juan et al. found a significantly higher TTP value in
irradiated parotid glands compared with non-irradiated
glands [8], which was in agreement with our
observation.
From pre-RT to post-RT, significant correlations were
found between parotid atrophy rate and the change rates
of ADC, f and MRE, while Marzi et al. also reported a
significant correlation between the change rate of ADC
values and parotid atrophy rate [9]. However, the
correlations were negative in our study and were positive
in Marzi et al.’s, probably due to the discrepancy in
follow-up time points between the two studies. The
follow-up time point in our study was 4 weeks after RT,
while Marzi et al. chose the same day as the completion
of RT. Four weeks after RT, interstitial fibrosis was ob-
served in irradiated parotid glands [26], which might
have contributed to the negative correlation between the
change rate of ADC value and the parotid atrophy rate
at 4 weeks after RT. Interstitial fibrosis could not fully
compensate for the increase in EES secondary to
radiation-induced parotid cell loss, but it reduced the
augmentation of the ADC value induced by the
increased EES. Moreover, greater parotid atrophy, indi-
cating more severe damage, was usually accompanied by
more interstitial fibrosis. Therefore, a greater parotid
atrophy rate might induce a smaller change rate in ADC
value due to the increase in interstitial fibrosis, although
Marzi et al. also reported a significant, positive correl-
ation between the change rate of f and the parotid atro-
phy rate on the same day as the completion of RT [9], in
contradiction of our observations as well. This difference
might also have resulted from the different MR examin-
ation time points between us. Xu et al. reported that the
parotid microvascular density in miniature pigs de-
creased by approximately 20 and 40 % at 4 h and 2 weeks
after irradiation (25 Gy), respectively [24]. According to
this finding, we could speculate that a greater parotid at-
rophy rate might be accompanied by more severe micro-
vascular damage at 4 weeks after RT. In our opinion,
radiation-induced vascular oedema was the main effect
in the early phase after RT, and the decreased micro-
vascular density could not adequately compensate for
and merely reduced the increase in blood volume in-
duced by vascular oedema. Therefore, a greater parotid
atrophy rate was accompanied by smaller change rates
of f and MRE from pre-RT to post-RT.
Good to excellent intra- and interobserver agreement
of parotid IVIM and DCE parameters was confirmed in
this study. Excellent intra- and interobserver agreement
of parotid IVIM MR parameters (D, D*, f ) was reported
by Su et al. and Xu et al. in healthy volunteers and in
patients with Sjögren’s Syndrome, respectively [20, 27].
However, Patel et al. reported good to excellent reprodu-
cibility for ADC, D and f and fair reproducibility for D*
on liver IVIM MR imaging [28]. The poor reproducibil-
ity of D* might have been due to the underlying breath-
ing motion artefacts on liver MR imaging, which were
absent on parotid MR imaging. In contrast, IVIM
perfusion-related parameters are mainly affected by low
b values (b ≤ 100 s/mm2) [12]. Five low b values (0, 25,
50, 75, 100 s/mm2) were adopted in our study, while
Patel et al. used only three low b values (0, 50, 100 s/
mm2) for liver IVIM MR imaging, which might be
Table 3 Correlations between atrophy rate and the change
rates of parotid IVIM or DCE MR parameters












RWash in Rate −0.136 0.428
IVIM Intravoxel incoherent motion, DCE Dynamic contrast-enhanced, r Pearson
correlation coefficient, RIVIM-PARsand RDCE-PARs are the change rates of IVIM and
DCE MR parameters from pre-RT to post-RT, respectively, RADC, RD, RD*, Rf, RMRE,
RTTPand RWash in Rate are the change rates of apparent diffusion coefficient
(ADC), pure diffusion coefficient (D), pseudo-diffusion coefficient (D*),
perfusion fraction (f), maximum relative enhancement (MRE), time to peak
(TTP) and Wash in Rate from pre-RT (2 weeks before radiotherapy) to post-RT
(4 weeks after RT), respectively
adenotes a significant correlation between the parotid atrophy rate and the
change rate of each IVIM or DCE MR parameter
Table 2 The IVIM and DCE MR parameters of parotid glands
pre-RT and post-RT
pre-RT post-RT p value
IVIM MR parameters
ADC (10−3 mm2/s) 0.88 ± 0.15 1.45 ± 0.20 <0.001a
D (10−3 mm2/s) 0.72 ± 0.13 1.16 ± 0.21 <0.001a
D* (10−3 mm2/s) 36.3 ± 22.7 50.8 ± 27.4 0.024a
f (%) 13.3 ± 3.9 19.2 ± 5.6 <0.001a
DCE parameters
MRE (%) 182.0 ± 41.3 287.1 ± 41.4 <0.001a
TTP (s) 42.4 ± 28.9 53.7 ± 26.0 0.037a
Wash in Rate (i/s) 97.5 ± 44.4 159.8 ± 54.5 <0.001a
IVIM Intravoxel incoherent motion, DCE Dynamic contrast-enhanced, pre-RT
Approximately 2 weeks before radiotherapy (RT), post-RT approximately
4 weeks after RT, ADC Apparent diffusion coefficient, D Pure diffusion
coefficient, D* Pseudo-diffusion coefficient, f perfusion fraction, MRE Maximum
relative enhancement, TTP Time to peak
adenotes a significant difference between pre-RT and post-RT parameters
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another reason for the poor reproducibility of D*
measurement in their study.
Based on our findings in this study, the radiation-
induced changes in the parotid microstructure could be
reflected by IVIM diffusion-related parameters (ADC,
D) noninvasively and quantitatively, and the radiation-
induced microvascular changes could be assessed by
IVIM perfusion-related parameters (f, D*), while parotid
IVIM perfusion-related parameters shared similar
Fig. 3 Scatter plots show that the change rates of apparent diffusion coefficient (ADC) (a), perfusion fraction (f) (b) and maximum relative
enhancement (MRE) (c) values are significantly correlated with the parotid atrophy rate from pre-RT (approximately 2 weeks before radiotherapy)
to post-RT (approximately 4 weeks after radiotherapy). RADC, Rf and RMRE are the change rates of ADC, f and MRE values from pre-RT to post-RT,
respectively. The dashed lines are the 95 % confidence bands
Table 4 Correlations between change rates of parotid IVIM and
DCE MR parameters
RIVIM-PARs RDCE-PARs r p value
RADC RMRE 0.103 0.550
RTTP −0.048 0.780
RWash in Rate −0.006 0.973
RD RMRE 0.191 0.264
RTTP 0.156 0.364
RWash in Rate 0.181 0.290




RWash in Rate 0.251 0.139
Rf RMRE −0.079 0.647
RTTP −0.238 0.162
RWash in Rate −0.116 0.500
IVIM Intravoxel incoherent motion, DCE dynamic contrast-enhanced, r Pearson
correlation coefficient, RIVIM-PARsand RDCE-PARs are the change rates of IVIM and
DCE MR parameters from pre-RT to post-RT, respectively, RADC, RD, RD*, Rf, RMRE,
RTTPand RWash in Rate are the change rates of apparent diffusion coefficient
(ADC), pure diffusion coefficient (D), pseudo-diffusion coefficient (D*),
perfusion fraction (f), maximum relative enhancement (MRE), time to peak
(TTP) and Wash in Rate from pre-RT (2 weeks before radiotherapy) to post-RT
(4 weeks after RT), respectively
adenotes a significant correlation between the change rates of IVIM and DCE
MR parameters
Table 5 Intra- and interobserver agreement (ICC) for the
measurements of parotid IVIM and DCE MR parameters
Intraobserver ICC Interobserver ICC
IVIM MR parameters
ADC 0.935 (0.895–0.959) 0.930 (0.889–0.956)
D 0.939 (0.902–0.962) 0.935 (0.896–0.959)
D* 0.793 (0.608–0.890) 0.638 (0.421–0.773)
f 0.655 (0.449–0.784) 0.633 (0.413–0.770)
DCE MR parameters
MRE 0.978 (0.965–0.986) 0.966 (0.933–0.983)
TTP 0.914 (0.863–0.964) 0.911 (0.826–0.955)
Wash in Rate 0.983 (0.974–0.990) 0.980 (0.960–0.990)
IVIM Intravoxel incoherent motion, DCE Dynamic contrast-enhanced, ICC
Intraclass correlation coefficient, ADC Apparent diffusion coefficient, D pure
diffusion coefficient, D* pseudo-diffusion coefficient, f perfusion fraction, MRE
maximum relative enhancement, TTP Time to peak. The numbers between
parentheses are 95 % confidence intervals
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change patterns with DCE MR parameters from pre-RT
to post-RT, which indicated that IVIM perfusion-related
parameters could serve as an alternative to DCE MR pa-
rameters in the evaluation of irradiated parotid micro-
vascular damage, especially for those patients with renal
insufficiency. Both IVIM and DCE MR imaging could
serve as objective modalities for evaluating irradiated
parotid damage, rather than subjective evaluation of the
degree of xerostomia. The change rates of parotid ADC,
f and MRE values were negatively correlated with the at-
rophy rate of the parotid gland from pre-RT to post-RT.
It was reported that the decreased parotid gland volume
was significantly correlated with decreased saliva pro-
duction in patients with head-and-neck cancer undergo-
ing RT [29]. The correlations between IVIM or DCE
MR parameters and parotid function indices (such as
saliva production) will be investigated in our future
study, and long-term follow-up will be performed to ex-
plore the prognostic values of IVIM and DCE MR pa-
rameters in evaluating the damage of irradiated parotid
glands. Based on the findings of IVIM or DCE MR im-
aging, radiation oncologists could perform early inter-
ventions to avoid long-term irreversible damage to the
parotid glands in NPC patients undergoing RT.
Our study had several limitations. Firstly, the sample
size was relatively small although larger than in some
other studies of MR imaging in the evaluation of
radiation-induced parotid damage [6, 10], and a larger
cohort of patients for the correlation of the change rates
of IVIM and DCE MR parameters might have been
more reliable. Secondly, the range of the mean parotid
radiation dose was relatively limited, which might have
obscured the relationships between the mean radiation
dose and parotid IVIM or DCE MR parameters. We aim
to enrol more patients with other head and neck tu-
mours to enlarge the range of the mean parotid radi-
ation dose in the future. Thirdly, the pathological
information of irradiated parotid glands in NPC patients
was absent in this study due to its invasiveness. Hence,
we should perform animal experiments to confirm our
hypotheses.
Conclusions
IVIM and DCE MR imaging can noninvasively evaluate
the pathophysiologic changes in irradiated parotid
glands, including necrosis of acinar cells, vascular
oedema and interstitial fibrosis. The IVIM and DCE MR
parameters in irradiated parotid glands shared the same
change patterns, and significant correlations were found
between the change rates of D* and MRE or TTP. IVIM
and DCE MR imaging could serve as objective, quantita-
tive and noninvasive modalities for evaluating irradiated
parotid damage.
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